Index | Gene Name Primary | Protein Name | Uniprot ID | Gene Name Synonym | Ligand Name | Structure | PDB Code | ligand desolvation | Ligand Structure | Compound Affinity nM |
1 | CATB | Cathepsin B | P07858 | CPSB | c1g | Structure of CathB with covalently linked Compound 28 | 6ay2 | 57.33 | | no data |
2 | CATC | Dipeptidyl peptidase 1 | P53634 | CPPI | lxv | Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C | 3pdf | 84.79 | | no data |
3 | CATF | Cathepsin F | Q9UBX1 | | myp | Crystal structure of human cathepsin F | 1m6d | 58.31 | | no data |
4 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | pos | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE INHIBITOR | 1au2 | 66.36 | | 13. |
5 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | o75 | Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group. | 3o1g | 62.22 | | 1. |
6 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | kwz | Cathepsin K in complex with a non-selective 2-cyano-pyrimidine inhibitor | 3kwz | 64.57 | | 4. |
7 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 7as | Crystal structure of Cathepsin K with a covalently-linked inhibitor at 1.4 Angstrom resolution. | 5tdi | 65 | | 0.18 |
8 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 4pr | Cathepsin K complexed with a pyrrolidine ketoamide-based inhibitor | 2bdl | 59.19 | | 15. |
9 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 3fc | Cathepsin K complexed with a constrained ketoamide inhibitor | 1yt7 | 67.2 | | 0.13 |
10 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 2ca | CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE INHIBITOR | 1nlj | 75.25 | | 0.16 |
11 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | i10 | CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC INHIBITOR | 1bgo | 69.88 | | 3.5 |
12 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | ihe | Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor NVP-ABE854 | 1u9v | 55.66 | | 6. |
13 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | ihi | Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor NVP-ABI491 | 1u9w | 62.28 | | 3.5 |
14 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | ihj | Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor NVP-ABJ688 | 1u9x | 54.05 | | 7. |
15 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | noq | A mutant rabbit cathepsin K with a nitrile inhibitor | 2f7d | 72.36 | | no data |
16 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | cke | Crystal structure of a pyrrolopyrimidine inhibitor in complex with human Cathepsin K | 2r6n | 66.73 | | 1. |
17 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | orh | Structure of CatK covalently bound to a dioxo-triazine inhibitor | 3kwb | 66.67 | | 17. |
18 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | kx1 | Cathepsin K in complex with a selective 2-cyano-pyrimidine inhibitor | 3kx1 | 52.11 | | 100. |
19 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | o96 | Cathepsin K in complex with a covalent inhibitor with a ketoamide warhead | 3ovz | 66.64 | | 8.7 |
20 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 0lc | Cathepsin K inhibitor | 4dmy | 72.18 | | 1. |
21 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | i37 | Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. | 4x6h | 85.24 | | no data |
22 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 3xt | Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. | 4x6h | 89.14 | | no data |
23 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 3y1 | Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. | 4x6i | 72.41 | | 10. |
24 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 3y2 | Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. | 4x6j | 73.9 | | 16. |
25 | CATK | Cathepsin K | P43235 | CTSO CTSO2 | 1xf | Human cathepsin K mutant C25S in complex with the allosteric effector NSC13345 | 5j94 | 71.05 | | no data |
26 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | yj8 | CATHEPSIN L WITH A NITRILE INHIBITOR | 2yj8 | 68.64 | | 6.5 |
27 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | yj2 | CATHEPSIN L WITH A NITRILE INHIBITOR | 2yj2 | 68.48 | | 12. |
28 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | xu5 | CATHEPSIN L WITH A NITRILE INHIBITOR | 2xu5 | 65.72 | | 130. |
29 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | xu3 | CATHEPSIN L WITH A NITRILE INHIBITOR | 2xu3 | 70.68 | | 160. |
30 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | djt | CATHEPSIN L WITH A NITRILE INHIBITOR | 2xu4 | 68.79 | | 340. |
31 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | c7t | CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(azetidin-3-yl)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6,8,10,14,18(22),19-heptaene-3-carboxamide | 6f06 | 65.01 | | no data |
32 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | 5t9 | CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2-yl)-azetidine-3-carbonyl]-pyrrolidine-2-carboxylic acid (1-cyano-cyclopropyl)-amide | 5f02 | 65.07 | | 36. |
33 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | 424 | CATHEPSIN L WITH A NITRILE INHIBITOR | 2xu1 | 68.19 | | 22. |
34 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | 424 | CATHEPSIN L WITH A NITRILE INHIBITOR | 2yjc | 68.01 | | 22. |
35 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | v65 | TRIAZINE CATHEPSIN INHIBITOR COMPLEX | 4axm | 64.22 | | 13. |
36 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | 7kn | CATHEPSIN L IN COMPLEX WITH (2S,4R)-4-(2-Chloro-4-methoxy-benzenesulfonyl)-1-[3-(5-chloro-pyridin-2-yl)-azetidine-3-carbonyl]-pyrrolidine-2-car boxylic acid (1-cyano-cyclopropyl)-amide | 5mae | 59.88 | | 146. |
37 | CATL1 | Cathepsin L1 | P07711 | CTSL1 | 7kh | CATHEPSIN L IN COMPLEX WITH 4-[cyclopentyl(imidazo[1,2-a]pyridin-2-ylmethyl)amino]-6-morpholino-1,3,5-triazine-2-carbonitrile | 5maj | 67.16 | | 35. |
38 | CATL2 | Cathepsin L2 | O60911 | CATL2 CTSL2 CTSU | 0iw | CRYSTAL STRUCTURE OF HUMAN CATHEPSIN V COMPLEXED WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR | 1fh0 | 64.87 | | no data |
39 | CATS | Cathepsin S | P25774 | | mo9 | Human Cathepsin S with inhibitor CRA-16981 | 2g7y | 74.63 | | no data |
40 | CATS | Cathepsin S | P25774 | | c71 | Human Cathepsin S with Inhibitor CRA-26871 | 2frq | 60.45 | | no data |
41 | CATS | Cathepsin S | P25774 | | bjy | Crystal structure of human Cathepsin-S with bound ligand | 5qcj | 54.11 | | no data |
42 | CATS | Cathepsin S | P25774 | | bjs | Crystal structure of human Cathepsin-S with bound ligand | 5qch | 58.37 | | no data |
43 | CATS | Cathepsin S | P25774 | | bg7 | Crystal structure of human Cathepsin-S with bound ligand | 5qc9 | 54.72 | | no data |
44 | CATS | Cathepsin S | P25774 | | bc7 | Crystal structure of human Cathepsin-S with bound ligand | 5qc4 | 56.73 | | 150. |
45 | CATS | Cathepsin S | P25774 | | b9y | Crystal structure of human Cathepsin-S with bound ligand | 5qc3 | 60.81 | | no data |
46 | CATS | Cathepsin S | P25774 | | b9s | Crystal structure of human Cathepsin-S with bound ligand | 5qc1 | 57.05 | | no data |
47 | CATS | Cathepsin S | P25774 | | b8y | Crystal structure of human Cathepsin-S with bound ligand | 5qbz | 53.28 | | no data |
48 | CATS | Cathepsin S | P25774 | | b8j | Crystal structure of human Cathepsin-S with bound ligand | 5qbu | 55.07 | | no data |
49 | CATS | Cathepsin S | P25774 | | 599 | Pyrazole-based Cathepsin S Inhibitors with Arylalkynes as P1 Binding Elements | 3iej | 61.4 | | 220. |
50 | CATS | Cathepsin S | P25774 | | gnf | Cathepsin S in complex with non-covalent 2-(Benzoxazol-2-ylamino)-acetamide | 2f1g | 70.95 | | 29. |
51 | CATS | Cathepsin S | P25774 | | crj | Cathepsin S with nitrile inhibitor | 2fq9 | 75.36 | | no data |
52 | CATS | Cathepsin S | P25774 | | crv | Human Cathepsin S with CRA-27934, a Nitrile Inhibitor | 2fra | 75.22 | | no data |
53 | CATS | Cathepsin S | P25774 | | c28 | Human Cathepsin S with Inhibitor CRA-29728 | 2ft2 | 73.2 | | no data |
54 | CATS | Cathepsin S | P25774 | | h7j | Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor. | 2h7j | 78.69 | | no data |
55 | CATS | Cathepsin S | P25774 | | h7j | Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor (Hexagonal spacegroup) | 2hxz | 76.44 | | no data |
56 | CATS | Cathepsin S | P25774 | | y11 | Cathepsin S complexed with Compound 15 | 2r9m | 72.78 | | 1.5 |
57 | CATS | Cathepsin S | P25774 | | y14 | Cathepsin S complexed with Compound 26 | 2r9n | 73.63 | | no data |
58 | CATS | Cathepsin S | P25774 | | 935 | 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important | 3n3g | 76.34 | | no data |
59 | CATS | Cathepsin S | P25774 | | 93n | 4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically important | 3n3g | 71 | | 58. |
60 | CATS | Cathepsin S | P25774 | | ef3 | 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors | 3n4c | 77.48 | | 9.5 |
61 | CATS | Cathepsin S | P25774 | | o64 | Cathepsin S in complex with a covalent inhibitor with an aldehyde warhead | 3ovx | 75.19 | | 31. |
62 | CATS | Cathepsin S | P25774 | | 2fc | Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor | 4p6e | 85.06 | | 1290. |
63 | CATS | Cathepsin S | P25774 | | 2fz | Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor. | 4p6g | 61.04 | | 7.7 |